Found: 6
Select item for more details and to access through your institution.
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2023, v. 28, n. 1, p. 1, doi. 10.1016/j.aohep.2022.100769
- By:
- Publication type:
- Article
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2020, v. 19, n. 6, p. 622, doi. 10.1016/j.aohep.2020.08.066
- By:
- Publication type:
- Article
CLINICAL AND EPIDEMIOLOGICAL PROFILE OF HCV GENOTYPE 3 PATIENTS IN SOUTHERN BRAZIL.
- Published in:
- Clinical & Biomedical Research, 2020, v. 40, n. 1, p. 7, doi. 10.22491/2357-9730.100617
- By:
- Publication type:
- Article
Are Noninvasive Methods Comparable to Liver Biopsy in Postoperative Patients After Roux-en-Y Gastric Bypass?
- Published in:
- Obesity Surgery, 2020, v. 30, n. 7, p. 2566, doi. 10.1007/s11695-020-04513-4
- By:
- Publication type:
- Article
Probiotic supplementation for 24 weeks in patients with non-alcoholic steatohepatitis: the PROBILIVER randomized clinical trial.
- Published in:
- Frontiers in Nutrition, 2024, p. 1, doi. 10.3389/fnut.2024.1362694
- By:
- Publication type:
- Article
HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients.
- Published in:
- International Journal of Hepatology, 2012, p. 1, doi. 10.1155/2012/576584
- By:
- Publication type:
- Article